JP2013515752A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515752A5
JP2013515752A5 JP2012546361A JP2012546361A JP2013515752A5 JP 2013515752 A5 JP2013515752 A5 JP 2013515752A5 JP 2012546361 A JP2012546361 A JP 2012546361A JP 2012546361 A JP2012546361 A JP 2012546361A JP 2013515752 A5 JP2013515752 A5 JP 2013515752A5
Authority
JP
Japan
Prior art keywords
carboline
cyclo
pharmaceutical composition
och
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546361A
Other languages
English (en)
Japanese (ja)
Other versions
JP5627705B2 (ja
JP2013515752A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DE2010/001530 external-priority patent/WO2011079841A1/de
Publication of JP2013515752A publication Critical patent/JP2013515752A/ja
Publication of JP2013515752A5 publication Critical patent/JP2013515752A5/ja
Application granted granted Critical
Publication of JP5627705B2 publication Critical patent/JP5627705B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546361A 2009-12-28 2010-12-28 聴力損傷および目まいの治療用のβ−カルボリン Active JP5627705B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102009060811.7 2009-12-28
DE102009060811 2009-12-28
US28239510P 2010-02-02 2010-02-02
US61/282,395 2010-02-02
PCT/DE2010/001530 WO2011079841A1 (de) 2009-12-28 2010-12-28 Beta-carboline zur behandlung von hörschäden und schwindel

Publications (3)

Publication Number Publication Date
JP2013515752A JP2013515752A (ja) 2013-05-09
JP2013515752A5 true JP2013515752A5 (enExample) 2013-10-24
JP5627705B2 JP5627705B2 (ja) 2014-11-19

Family

ID=44246908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546361A Active JP5627705B2 (ja) 2009-12-28 2010-12-28 聴力損傷および目まいの治療用のβ−カルボリン

Country Status (17)

Country Link
US (1) US9107914B2 (enExample)
EP (1) EP2519238B1 (enExample)
JP (1) JP5627705B2 (enExample)
KR (1) KR20120098855A (enExample)
CN (1) CN102844029A (enExample)
AU (1) AU2010338669A1 (enExample)
BR (1) BR112012015967B1 (enExample)
CA (1) CA2785233C (enExample)
DE (1) DE112010005017A5 (enExample)
IL (1) IL220661A (enExample)
IN (1) IN2012DN05066A (enExample)
MX (1) MX2012007678A (enExample)
NZ (1) NZ600478A (enExample)
RU (1) RU2012132429A (enExample)
SG (1) SG181599A1 (enExample)
WO (1) WO2011079841A1 (enExample)
ZA (1) ZA201204476B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015023261A2 (pt) 2013-03-14 2017-07-18 Massachusetts Inst Technology composições e métodos para expansão e cultura de células-tronco epiteliais
SI2968284T1 (sl) 2013-03-14 2021-08-31 Osteoqc Inc. Alkil-amin harmin derivati za pospeševanje rasti kosti
EP2853533A1 (de) * 2013-09-29 2015-04-01 Audiocure Pharma GmbH 6-Fluor-9-methyl-ß-carbolin
CN107073042A (zh) 2014-09-03 2017-08-18 布里格海姆妇女医院公司 用于产生内耳毛细胞来治疗听力损失的组合物、系统和方法
CA3010610A1 (en) 2016-01-08 2017-07-13 The Brigham And Women's Hospital, Inc. Production of differentiated enteroendocrine cells and insulin producing cells
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
EP3321264A1 (en) * 2016-11-14 2018-05-16 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Selective inhibitors of genotoxic stress-induced ikk/nf-kb pathways
AU2017386417B2 (en) 2016-12-30 2022-07-14 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
JP7695496B2 (ja) 2018-08-14 2025-06-19 オシフィ セラピューティクス リミティド ライアビリティ カンパニー フルオロβ-カルボリン化合物
EP3836923B1 (en) 2018-08-14 2024-10-16 OssiFi Therapeutics LLC Pyrrolo - dipyridine compounds for the treatment of bone loss
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
WO2020037323A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating jag-1
EP3849530A4 (en) 2018-09-12 2022-06-22 Hough Ear Institute METHODS OF TREATMENT OF HEARING LOSS AFTER COCHLEAR IMPLANT SURGERY
EP3772515A1 (en) * 2019-08-09 2021-02-10 Audiocure Pharma GmbH Stable polymorphic form of 6-fluoro-9-methyl-9h-ss-carboline and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3240514A1 (de) 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
CA2140722A1 (en) 1994-01-24 1995-07-25 Joseph A. Jakubowski Beta-carboline thromboxane synthase inhibitors
US20040038970A1 (en) * 1998-06-12 2004-02-26 Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. Beta-carboline compounds
EP1086101B1 (en) * 1998-06-12 2002-12-18 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Beta-carboline compounds
US20050137220A1 (en) * 2003-07-23 2005-06-23 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
DE102007009264A1 (de) * 2007-02-26 2008-08-28 Ellneuroxx Ltd. 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen

Similar Documents

Publication Publication Date Title
RU2012132429A (ru) Бета-карболины для лечения нарушения слуха и головокружения
WO2012125926A3 (en) Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
JP2015523546A5 (enExample)
JP2015510941A5 (enExample)
JP2018035197A5 (enExample)
JP2011201907A5 (enExample)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
JP2013510120A5 (enExample)
JP2015025011A5 (enExample)
JP2011529070A5 (enExample)
JP2009542815A5 (enExample)
JP2011507896A5 (enExample)
RU2012107109A (ru) Бициклическое соединение и его применение для медицинских целей
JP2006528685A5 (enExample)
JP2014531441A5 (enExample)
JP2005527605A5 (enExample)
JP2019535723A5 (enExample)
RU2012112050A (ru) Производные дигидроптеридинона, способ их получения и фармацевтическое применение
JP2015511609A5 (enExample)
RU2017118405A (ru) Новое лечение роговицы с применением ламинина
JP2015051983A5 (enExample)
JP2015535247A5 (enExample)
WO2016171152A1 (ja) 角膜障害の治療剤、改善剤または予防剤
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
RU2017121203A (ru) НОВЫЕ ПОЛИМЕРНЫЕ hGH ПРОЛЕКАРСТВА